25th Aug 2005 11:30
SHIRE PHARMACEUTICALS GROUP PLCBLOCK LISTING SIX MONTHLY REVIEW1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: ROBERTS PHARMACEUTICALS OPTION SCHEME 3. PERIOD OF RETURN: FROM: 01 JANUARY 2005 TO: 30 JUNE 2005 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEMEAT END OF THE LAST PERIOD: 25,038,293 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 0 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 25,038,293 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES)ORIGINALLY LISTED: 134,788,867 AND THE DATE OF ADMISSION: 22 DECEMBER 1999 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD INORDER FOR US TO UPDATE OUR RECORDS. 492,654,408 BLOCK LISTING SIX MONTHLY REVIEW1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: STOCK PURCHASE PLAN 3. PERIOD OF RETURN: FROM: 01 JANUARY 2005 TO: 30 JUNE 2005 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEMEAT END OF THE LAST PERIOD: 806,323 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 13,635 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 792,688 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES)ORIGINALLY LISTED: 1,011,958 AND THE DATE OF ADMISSION: 2 APRIL 1996 (A FURTHER LISTING OF 513,488 SHARES WAS GRANTED ON 19 APRIL 2002)(A FURTHER LISTING OF 100,000 SHARES WAS GRANTED ON 12 JUNE 2002)(A FURTHER LISTING OF 1,000,000 SHARES WAS GRANTED ON 8 JULY 2004)PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIODIN ORDER FOR US TO UPDATE OUR RECORDS. 492,654,408 BLOCK LISTING SIX MONTHLY REVIEW1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: "B" EXECUTIVE SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 01 JANUARY 2005 TO: 30 JUNE 2005 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEMEAT END OF THE LAST PERIOD: 258,430 5. NUMBER OF SHARES ISSUED/ALLOTTED 2,219,359 UNDER SCHEME DURING PERIOD: 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 539,321 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES)ORIGINALLY LISTED: 1,750,000 AND THE DATE OF ADMISSION: 12 MARCH 1999 (A FURTHER LISTING OF 3,250,000 SHARES WAS GRANTED IN AUGUST 2001)(A FURTHER LISTING OF 250,000 SHARES WAS GRANTED IN SEPTEMBER 2003)(A FURTHER LISTING OF 2,500,000 SHARES WAS GRANTED IN JANUARY 2005)PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD INORDER FOR US TO UPDATE OUR RECORDS. 492,654,408 BLOCK LISTING SIX MONTHLY REVIEW1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: "A" EXECUTIVE SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 01 JANUARY 2005 TO: 30 JUNE 2005 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEMEAT END OF THE LAST PERIOD: 135,427 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 26,418 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 109,009 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES)ORIGINALLY LISTED: 250,000 AND THE DATE OF ADMISSION: 12 MARCH 1999 (A FURTHER LISTING OF 200,000 SHARES WAS GRANTED ON 19 APRIL 2002)PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD INORDER FOR US TO UPDATE OUR RECORDS. 492,654,408 BLOCK LISTING SIX MONTHLY REVIEW1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: SHIRE PHARMACEUTICALS SHARESAVE SCHEME 3. PERIOD OF RETURN: FROM: 01 JANUARY 2005 TO: 30 JUNE 2005 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEMEAT END OF THE LAST PERIOD: 47,444 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 1,173 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 45,624 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES)ORIGINALLY LISTED: 247,500 AND THE DATE OF ADMISSION: 21 AUGUST 1999 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD INORDER FOR US TO UPDATE OUR RECORDS. 492,654,408 BLOCK LISTING SIX MONTHLY REVIEW1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: SHIRE RICHWOOD INC SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 01 JANUARY 2005 TO: 30 JUNE 2005 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEMEAT END OF THE LAST PERIOD: 388,852 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: NIL 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 388,852 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES)ORIGINALLY LISTED: 1,597,816 AND THE DATE OF ADMISSION: 31 MARCH 1999 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD INORDER FOR US TO UPDATE OUR RECORDS. 492,654,408 BLOCK LISTING SIX MONTHLY REVIEW1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: SHIRE LABORATORIES INC SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 01 JANUARY 2005 TO: 30 JUNE 2005 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEMEAT END OF THE LAST PERIOD: 7,843 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 5,503 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 3,609 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES)ORIGINALLY LISTED: 1,741,654 AND THE DATE OF ADMISSION: 18 MARCH 1998 (A FURTHER LISTING OF 390,226 SHARES WAS GRANTED ON 31 MARCH 1999)PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD INORDER FOR US TO UPDATE OUR RECORDS. 492,654,408 BLOCK LISTING SIX MONTHLY REVIEW1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: SHIRE HOLDINGS LTD SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 01 JANUARY 2005 TO: 30 JUNE 2005 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEMEAT END OF THE LAST PERIOD: 3,040 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: NIL 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 3,040 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES)ORIGINALLY LISTED: 1,011,958 AND THE DATE OF ADMISSION: 31 MARCH 1999 (A FURTHER LISTING OF 318,912 SHARES WAS GRANTED ON 19 APRIL 2002)PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD INORDER FOR US TO UPDATE OUR RECORDS. 492,654,408 BLOCK LISTING SIX MONTHLY REVIEW1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: SHIRE BIOCHEM STOCK OPTION PLAN 3. PERIOD OF RETURN: FROM: 01 JANUARY 2005 TO: 30 JUNE 2005 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEMEAT END OF THE LAST PERIOD: 5,292,951 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 31,859 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 5,261,092 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES)ORIGINALLY LISTED: 14,822,713 AND THE DATE OF ADMISSION: AUGUST 2001 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD INORDER FOR US TO UPDATE OUR RECORDS. 492,654,408 BLOCK LISTING SIX MONTHLY REVIEW1. NAME OF COMPANY: SHIRE PHARMACEUTICALS GROUP PLC 2. NAME OF SCHEME: TPC WARRANTS 3. PERIOD OF RETURN: FROM: 01 JANUARY 2005 TO: 30 JUNE 2005 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEMEAT END OF THE LAST PERIOD: 1,346,407 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: NIL 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 1,346,407 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES)ORIGINALLY LISTED: 741,812 AND THE DATE OF ADMISSION: 29 APRIL 2002 (A FURTHER LISTING OF 604,595 SHARES WAS GRANTED ON 27 NOVEMBER 2002)PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD INORDER FOR US TO UPDATE OUR RECORDS. 492,654,408 For further information please contact:Vivienne Hemming - Deputy Company Secretary +44 1256 894 276 Notes to editorsShire Pharmaceuticals Group plcShire Pharmaceuticals Group plc (Shire) is a global specialty pharmaceuticalcompany with a strategic focus on meeting the needs of the specialist physicianand currently focuses on developing and marketing products in the areas ofcentral nervous system (CNS), gastrointestinal (GI), renal diseases and humangenetics. Shire has operations in the world's key pharmaceutical markets (US,Canada, UK, France, Italy, Spain and Germany) as well as a specialist drugdelivery unit in the US.For further information on Shire, please visit the Company's website: www.shire.com. 10Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com Press Release Registered in England 2883758 Registered Office as aboveENDShire Pharmaceuticals Group PLCRelated Shares:
Shire